rs3212369

Variant names:

• chr16-89920352-A-G
• rs3212369
• NM_002386.4:c.*140A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_002386.4(MC1R):​c.*140A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 756,892 control chromosomes in the GnomAD database, including 13,290 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.22 (4352 hom., cov: 32)
  • Exomes 𝑓: 0.16 (8938 hom.)
• Consequence: MC1R NM_002386.4 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:3
• Conservation: PhyloP100: 0.774
• Publications: 13 publications found

Genes affected

MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

ENSG00000198211 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.87).
• BP6: Variant 16-89920352-A-G is Benign according to our data. Variant chr16-89920352-A-G is described in ClinVar as Benign. ClinVar VariationId is 321444.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002386.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	MC1R	NM_002386.4	MANE Select	c.*140A>G		3_prime_UTR	Exon 1 of 1	NP_002377.4

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	MC1R	ENST00000555147.2	TSL:6 MANE Select	c.*140A>G		3_prime_UTR	Exon 1 of 1	ENSP00000451605.1
	ENSG00000198211	ENST00000556922.1	TSL:2	c.950+144A>G		intron	N/A	ENSP00000451560.1
	ENSG00000259006	ENST00000554623.1	TSL:3	n.460T>C		non_coding_transcript_exon	Exon 2 of 2

Frequencies

GnomAD3 genomes AF: 0.219 AC: 33349 AN: 152006 Hom.: 4344 Cov.: 32

Gnomad AFR AF: 0.365

Gnomad AMI AF: 0.115

Gnomad AMR AF: 0.158

Gnomad ASJ AF: 0.154

Gnomad EAS AF: 0.268

Gnomad SAS AF: 0.125

Gnomad FIN AF: 0.104

Gnomad MID AF: 0.275

Gnomad NFE AF: 0.170

Gnomad OTH AF: 0.213

GnomAD4 exome AF: 0.163 AC: 98548 AN: 604768 Hom.: 8938 Cov.: 7 AF XY: 0.161 AC XY: 50284 AN XY: 312582

African (AFR) AF: 0.364 AC: 5490 AN: 15092

American (AMR) AF: 0.128 AC: 3006 AN: 23574

Ashkenazi Jewish (ASJ) AF: 0.154 AC: 2369 AN: 15432

East Asian (EAS) AF: 0.172 AC: 5479 AN: 31922

South Asian (SAS) AF: 0.117 AC: 5842 AN: 50136

European-Finnish (FIN) AF: 0.106 AC: 4766 AN: 44754

Middle Eastern (MID) AF: 0.252 AC: 932 AN: 3692

European-Non Finnish (NFE) AF: 0.166 AC: 64694 AN: 389186

Other (OTH) AF: 0.193 AC: 5970 AN: 30980

GnomAD4 genome AF: 0.219 AC: 33377 AN: 152124 Hom.: 4352 Cov.: 32 AF XY: 0.211 AC XY: 15679 AN XY: 74376

African (AFR) AF: 0.365 AC: 15112 AN: 41458

American (AMR) AF: 0.158 AC: 2417 AN: 15298

Ashkenazi Jewish (ASJ) AF: 0.154 AC: 535 AN: 3470

East Asian (EAS) AF: 0.269 AC: 1390 AN: 5160

South Asian (SAS) AF: 0.126 AC: 610 AN: 4828

European-Finnish (FIN) AF: 0.104 AC: 1104 AN: 10596

Middle Eastern (MID) AF: 0.282 AC: 83 AN: 294

European-Non Finnish (NFE) AF: 0.170 AC: 11574 AN: 67996

Other (OTH) AF: 0.212 AC: 447 AN: 2112

Alfa AF: 0.201 Hom.: 2164

Bravo AF: 0.231

Asia WGS AF: 0.214 AC: 746 AN: 3478

ClinVar

ClinVar submissions as Germline

Significance: Benign

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	-	2	not provided (2)
-	-	1	Melanoma, cutaneous malignant, susceptibility to, 5 (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.87
CADD	Benign	3.1
DANN	Benign	0.57
PhyloP100		0.77
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs3212369; hg19: chr16-89986760; COSMIC: COSV59624658; COSMIC: COSV59624658;